Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Deaths from cardiovascular disease higher in winter and lower in summer, says doctor

Dr Marques-Vidal said: "Deaths from cardiovascular disease are higher in winter and lower in summer. We decided to conduct a large scale study to see whether cardiovascular risk factors have a seasonal pattern which could explain the seasonality in deaths."

2 Sep 2013

Findings could alter ways in which doctors use platelets to treat traumatic injuries

A new finding could lead to novel treatments to reduce bleeding in trauma and severe infections.

2 Sep 2013

Life expectancy gap growing between older women in rich and poor countries: Study

Measures taken in developed countries to reduce noncommunicable diseases - the leading causes of death globally - have improved the life expectancy of women aged 50 years and older over the last 20 to 30 years.

2 Sep 2013

BUSM professors suggest importance of eliminating healthy obese persons from unnecessary treatments

With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.

31 Aug 2013

Statins offer great potential as anti-aging therapy

Not only do statins extend lives by lowering cholesterol levels and reducing the risks of cardiovascular disease, but new research in the September 2013 issue of The FASEB Journal suggests that they may extend lifespans as well. Specifically, statins may reduce the rate at which telomeres shorten, a key factor in the natural aging process. This opens the door for using statins, or derivatives of statins, as an anti-aging therapy.

30 Aug 2013

Dezima starts DEZ-001 Phase 2b study in patients with mild dyslipidemia

Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the initiation of a double blind, placebo controlled, Phase 2b dose ranging study of DEZ-001 (previously TA-8995), alone and in combination with statins, in order to study the effects on a wide range of lipids and other biomarkers of cardiovascular disease in patients with mild dyslipidemia.

30 Aug 2013

Study suggests evaluations of ACO programs may need to consider patient utilization of clinical, economic benefits

Payment incentives implemented with a commercial accountable care organization (ACO) initiative in Massachusetts -Blue Cross Blue Shield's Alternative Quality Contract (AQC) - were associated with lower spending for Medicare enrollees served by the provider groups participating in the AQC, findings that suggest that evaluations of ACO programs may need to consider the implications for other patient populations to assess their full clinical and economic benefits, according to a study in the August 28 issue of JAMA.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

New clinical recommendations urge women to maintain periodontal health during pregnancy

When a woman becomes pregnant, she knows it is important to maintain a healthy lifestyle to ensure both the health of herself and the health of her baby. New clinical recommendations from the American Academy of Periodontology and the Eurpean Federation of Periodontology urge pregnant women to maintain periodontal health as well.

29 Aug 2013

Respicardia reports successful implant of remede System for CSA patients

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.

28 Aug 2013

New polymer additives enhance ability of oral drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed — a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

28 Aug 2013

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Joslin scientists, in collaboration with researchers from the Harvard School of Public Health and Italian research institutes, have identified a previously unknown genetic variant associated with an increased risk of coronary heart disease (CHD) in type 2 diabetic patients.

28 Aug 2013

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Women undergoing treatment for breast cancer are widely prescribed calcium and vitamin D supplements to prevent and manage osteoporosis, an unwanted side effect of breast cancer therapies.

28 Aug 2013

Personalised management: The only way to close mortality gap for AF patients

Personalised management is the only way to close the mortality gap for patients with atrial fibrillation, according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).

27 Aug 2013

Unique computer technology opens up discovery of smarter drugs to treat illnesses

A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Healthy and obese kids who participated in lifestyle modification program show improved heart health

A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.

23 Aug 2013

Study confirms exposure to arsenic in drinking water can impair lung function

A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water-about 12 times the dose generally considered safe-produced lung damage comparable to decades of smoking tobacco. Smoking, especially by males, made arsenic-related damage even worse.

23 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Deaths from cardiovascular disease higher in winter and lower in summer, says doctor

Findings could alter ways in which doctors use platelets to treat traumatic injuries

Life expectancy gap growing between older women in rich and poor countries: Study

BUSM professors suggest importance of eliminating healthy obese persons from unnecessary treatments

Statins offer great potential as anti-aging therapy

Dezima starts DEZ-001 Phase 2b study in patients with mild dyslipidemia

Study suggests evaluations of ACO programs may need to consider patient utilization of clinical, economic benefits

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

New clinical recommendations urge women to maintain periodontal health during pregnancy

Respicardia reports successful implant of remede System for CSA patients

New polymer additives enhance ability of oral drugs to reach bloodstream

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Personalised management: The only way to close mortality gap for AF patients

Unique computer technology opens up discovery of smarter drugs to treat illnesses

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Healthy and obese kids who participated in lifestyle modification program show improved heart health

Study confirms exposure to arsenic in drinking water can impair lung function

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in